Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOTOX for chronic migraine prophylaxis (PREEMPT 1)
NCT00156910Phase 3Completed
- Sponsor
- Allergan
- Start
- Feb 2006
- Primary completion
- Nov 2007
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in chronic migraine (CM) comparing BOTOX Arm with Placebo Arm (2 arms). Primary endpoint: Change in Frequency of Headache Episodes at 24 weeks. Started Feb 2006; status: completed.
02
Drugs
onabotulinumtoxinA
03
Conditions
chronic migraine (CM)
Beyond the preview
Go deeper on NCT00156910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00156910.